Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

✍ Scribed by I Judson; J.A Radford; M Harris; J.-Y Blay; Q van Hoesel; A le Cesne; A.T van Oosterom; M.J Clemons; C Kamby; C Hermans; J Whittaker; E Donato di Paola; J Verweij; S Nielsen

• Book ID: 117657179
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 150 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)00050-8